Apollomics
APLM
4 hedge funds and large institutions have $1.58K invested in Apollomics in 2025 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0.66% less ownership
Funds ownership: 0.67% → 0.01% (-0.66%)
97% less capital invested
Capital invested by funds: $48.2K → $1.58K (-$46.6K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$45.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HI
1
Harbour Investments
Madison,
Wisconsin
| $922 | – | – | – |
|
|
SS
2
SBI Securities
Tokyo,
Japan
| $350 | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $295 | -$45.4K | -7,267 | -100% |
|
4
BlackRock
New York
| $18 | – | – | – |
|
APLM Hedge Fund Activity: Q3 2025 in Review
4 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Apollomics (APLM) for Q3 2025, worth a combined $1.58K — down 97% from $48.2K a quarter earlier.
Fund positioning in APLM was balanced in Q3 2025: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was UBS Group, cutting an estimated $45.4K.
- 4 institutional investors held Apollomics (APLM) as of Q3 2025, unchanged from Q2 2025.
- Funds reported $1.58K of Apollomics stock for Q3 2025, down 97% quarter-over-quarter.
- 0 funds opened new Apollomics positions in Q3 2025 and 0 closed out.
- The largest Apollomics seller in Q3 2025 was UBS Group, an estimated $45.4K sold.
Based on aggregated 13F filings for Q3 2025.